RNA sequencing results from other recent studies, for example by Lehman et al. 17, also suggest that high SSTR2 expression correlates with unfavorable outcomes in non-metastasized SCLC, emphasizing a role of SSTR2 signaling in progression and survival of tumor cells. This evidence concerns the gene SSTR2 and neoplasm.